Latest Continuous Disclosure News

Page 44 of 63
Trigg Minerals has disclosed a significant acquisition of the Tennessee Mountain tungsten project in Nevada, explaining recent unusual trading activity in its shares. The company confirms compliance with ASX disclosure rules and plans a full announcement before market open on August 7, 2025.
Maxwell Dee
Maxwell Dee
7 Aug 2025
SRJ Technologies clarifies its financial position and strategic rationale behind a recent capital raise and acquisition of a UAE entity, addressing ASX concerns over its viability and voluntary suspension.
Maxwell Dee
Maxwell Dee
7 Aug 2025
SportsHero Limited has responded to ASX queries about recent unusual trading activity, confirming no undisclosed price-sensitive information and ongoing compliance with disclosure rules.
Sophie Babbage
Sophie Babbage
6 Aug 2025
Rhythm Biosciences has responded to an ASX price query following a sudden surge in its share price and trading volume, confirming no undisclosed information is driving the activity.
Ada Torres
Ada Torres
6 Aug 2025
Mayne Pharma has firmly rejected a fresh termination notice from Cosette Pharmaceuticals alleging breaches related to FDA disclosure, escalating an ongoing contractual dispute with significant legal implications.
Ada Torres
Ada Torres
5 Aug 2025
Orcoda Limited has clarified the materiality and timing of disclosures related to its ACTA trial and new SaaS contracts, confirming compliance with ASX Listing Rules and explaining the rationale behind its announcements.
Sophie Babbage
Sophie Babbage
5 Aug 2025
Boss Energy has acknowledged significant upward revisions to operating and capital costs at its Honeymoon Uranium Project, alongside challenges in achieving production targets, prompting an independent review.
Maxwell Dee
Maxwell Dee
5 Aug 2025
Leeuwin Metals Ltd has addressed a sudden spike in its share price and trading volume, confirming no undisclosed material information exists and attributing the movement to external market factors and a new research report.
Maxwell Dee
Maxwell Dee
4 Aug 2025
Hudson Investment Group faces intense scrutiny from ASX after its auditor issued a Disclaimer of Opinion on the 2024 financial report, citing doubts over a $2.4 million property receivable and the company’s going concern status.
Claire Turing
Claire Turing
4 Aug 2025
Alterity Therapeutics faces ASX scrutiny after mistakenly marking multiple announcements as market sensitive, prompting a review of its disclosure practices. The biotech denies any intent to manipulate its share price despite repeated errors.
Ada Torres
Ada Torres
4 Aug 2025
The Lederer Group has made an unsolicited off-market takeover offer for Elanor Commercial Property Fund at 70 cents per security, prompting the Fund's board to carefully consider its response.
Eva Park
Eva Park
4 Aug 2025
Unith Ltd has acknowledged a technical breach of its trading policy following a director's share purchase during a closed period, prompting a comprehensive review of its governance framework.
Claire Turing
Claire Turing
4 Aug 2025